83 related articles for article (PubMed ID: 20632819)
1. Immunocytochemical localisation of caspase-3 in pancreatic islets from type 2 diabetic subjects.
Tomita T
Pathology; 2010; 42(5):432-7. PubMed ID: 20632819
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical localization of cleaved caspase-3 in pancreatic islets from type 1 diabetic subjects.
Tomita T
Islets; 2010; 2(1):24-9. PubMed ID: 21099290
[TBL] [Abstract][Full Text] [Related]
3. Amyloid oligomers in diabetic and nondiabetic human pancreas.
Zhao HL; Sui Y; Guan J; He L; Gu XM; Wong HK; Baum L; Lai FM; Tong PC; Chan JC
Transl Res; 2009 Jan; 153(1):24-32. PubMed ID: 19100955
[TBL] [Abstract][Full Text] [Related]
4. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.
Clark A; Wells CA; Buley ID; Cruickshank JK; Vanhegan RI; Matthews DR; Cooper GJ; Holman RR; Turner RC
Diabetes Res; 1988 Dec; 9(4):151-9. PubMed ID: 3073901
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
Tomita T
Islets; 2012; 4(3):223-32. PubMed ID: 22847497
[TBL] [Abstract][Full Text] [Related]
6. Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.
Tomita T
Islets; 2011; 3(4):166-74. PubMed ID: 21633185
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
Clark A; Matthews DR; Naylor BA; Wells CA; Hosker JP; Turner RC
Diabetes Res; 1987 Feb; 4(2):51-5. PubMed ID: 2884060
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
de Koning EJ; Fleming KA; Gray DW; Clark A
J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
[TBL] [Abstract][Full Text] [Related]
9. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
Iki K; Pour PM
J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
[TBL] [Abstract][Full Text] [Related]
10. Amyloidosis of pancreatic islets in primary amyloidosis (AL type).
Tomita T
Pathol Int; 2005 Apr; 55(4):223-7. PubMed ID: 15826250
[TBL] [Abstract][Full Text] [Related]
11. Higher islet amyloid load in men than in women with type 2 diabetes mellitus.
Zhao HL; Sui Y; Guan J; He L; Lai FM; Zhong DR; Yang D; Baum L; Tong PC; Tomlinson B; Chan JC
Pancreas; 2008 Oct; 37(3):e68-73. PubMed ID: 18815541
[TBL] [Abstract][Full Text] [Related]
12. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
[TBL] [Abstract][Full Text] [Related]
13. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
[TBL] [Abstract][Full Text] [Related]
14. Cleaved caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors: A potential marker for biological malignancy.
Tomita T
Islets; 2010; 2(2):82-8. PubMed ID: 21099299
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative estimation of pancreatic islet cells in diabetes mellitus].
Liu TH
Zhonghua Yi Xue Za Zhi; 1989 Feb; 69(2):83-5, 8. PubMed ID: 2670104
[TBL] [Abstract][Full Text] [Related]
16. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
17. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
[TBL] [Abstract][Full Text] [Related]
19. Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats.
Janssen SW; Hermus AR; Lange WP; Knijnenburg Q; van der Laak JA; Sweep CG; Martens GJ; Verhofstad AA
Exp Clin Endocrinol Diabetes; 2001; 109(5):273-82. PubMed ID: 11507651
[TBL] [Abstract][Full Text] [Related]
20. Glycosylphosphatidylinositol-specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes.
Larson DM; Kennedy MA; Bowen RF; Verchere CB; Deeg MA
J Pathol; 2004 Aug; 203(4):961-7. PubMed ID: 15259000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
